Australia markets closed

Chimerix, Inc. (CMRX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.8900+0.0047 (+0.53%)
At close: 04:00PM EDT
0.9000 +0.01 (+1.12%)
After hours: 07:07PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.8853
Open0.9100
Bid0.8859 x 200
Ask0.9219 x 100
Day's range0.8810 - 0.9100
52-week range0.7800 - 1.3000
Volume144,869
Avg. volume224,072
Market cap79.771M
Beta (5Y monthly)1.19
PE ratio (TTM)N/A
EPS (TTM)-0.9400
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est7.00
  • GlobeNewswire

    Chimerix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    DURHAM, N.C., July 05, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ:CMRX), today announced that on July 1, 2024, the Compensation Committee of Chimerix’s Board of Directors granted inducement awards to two new employees of non-statutory stock options to purchase up to a total of 120,000 shares of Chimerix’s common stock. The Compensation Committee of Chimerix’s Board of Directors approved the awards as an inducement material to the new employees’ employment in accordance with Nasdaq Listing rule 56

  • GlobeNewswire

    Chimerix to Participate in Fireside Chat at Jefferies Global Healthcare Conference

    DURHAM, N.C., May 30, 2024 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Andriole, Chief Executive Officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Thursday, June 6, 2024 at 3:00 p.m. ET. An audio webcast of the panel discussion will be available on the Investor Relations secti

  • Insider Monkey

    Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript

    Chimerix, Inc. (NASDAQ:CMRX) Q1 2024 Earnings Call Transcript May 1, 2024 Chimerix, Inc. misses on earnings expectations. Reported EPS is $-0.25 EPS, expectations were $-0.21. Chimerix, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning, ladies and gentlemen, […]